GLP3 R

Sold by case = 10 vials

Retatrutide

For Research Use Only. Not for Human or Veterinary Consumption.

Commonly marketed as Retatrutide, this is a synthetic peptide studied in laboratory research as a multi-receptor agonist targeting GLP-1, GIP, and glucagon receptors. Researchers utilize Retatrutide to explore its combined effects on metabolic regulation, appetite suppression, and energy expenditure in experimental models. This peptide supports advanced studies into integrated hormonal pathways involved in glucose homeostasis and weight management.

This compound is intended exclusively for qualified laboratory research. Not approved for therapeutic, diagnostic, or human use.

Mechanisms of Action

• Acts as a triple agonist targeting GLP-1, GIP, and glucagon receptors, studied for synergistic metabolic regulation in laboratory models.

• Investigated for effects on appetite suppression and energy expenditure through combined receptor activation.

• Explored for modulation of glucose homeostasis and lipid metabolism in experimental research.

• Supports research into integrated hormonal pathways influencing body weight and metabolic health under controlled conditions.